John A. Paganelli - 18 Jun 2026 Form 4 Insider Report for OPKO HEALTH, INC. (OPK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Jun 2026, 17:36:03 UTC
Prior SEC filing
20 Mar 2026
Next SEC filing
05 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Steven D. Rubin, Attorney-in-Fact
Filing notes and source

Key filing fact

John A. Paganelli filed Form 4 for OPKO HEALTH, INC. (OPK) on 22 Jun 2026.

Key facts

  • This page summarizes John A. Paganelli's Form 4 filing for OPKO HEALTH, INC. (OPK).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 22 Jun 2026, 17:36.

Change

  • Previous filing in this sequence was filed on 20 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001236687 Primary reporting owner

PAGANELLI JOHN A

Relationship
Director
Address
OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI
Signature
Steven D. Rubin, Attorney-in-Fact
Signature date
22 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OPK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+30,000
Change %
Price
$0.000000*
Shares after
30,000
Date
18 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$1.42
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .